Foods · Nov 15, 2026

Synbiotic Fortification of Yogurt with 2′-Fucosyllactose Ameliorates Estrogen Deficiency-Induced Postmenopausal Osteoporosis in Rats

By Yang L, Su S, Liu J et al.

Postmenopausal osteoporosis (PMO) caused by estrogen deficiency remains a major global health challenge, yet safe and effective nutritional strategies to alleviate its associated bone loss are limited. Here we developed two synbiotic yogurt formulations comprising 2′-fucosyllactose (2′-FL) as a functional prebiotic and either Bifidobacterium lactis M8 or B. lactis Ca360 as the live probiotic component, with the yogurt matrix serving as a protective delivery vehicle. We evaluated their effects in ovariectomized female Sprague–Dawley rats following 11 weeks of administration by oral gavage. Micro-computed tomography, histological analyses, enzyme-linked immunosorbent assays and immunohistochemistry demonstrated that synbiotic yogurt was more effective than chondroitin sulfate in attenuating bone loss and intestinal dysfunction induced by estrogen deficiency. It significantly ameliorated bone mineral density deterioration, restored OPG/RANKL balance, reduced serum CTX-I levels, restored intestinal barrier integrity, and downregulated pro-osteoclastogenic cytokines (IL-1β, IL-6, IL-17A, TNF-α). 16S rRNA gene sequencing showed that it altered gut microbial composition, enriching beneficial Lactobacillus, Romboutsia and Monoglobus, and depleting pro-inflammatory Candidatus_Saccharimonas. Synbiotic yogurt fortified with 2′-FL attenuated bone loss in rats, remodeled the gut microbiota, restored intestinal barrier integrity, reduced intestinal inflammation and suppressed inflammatory osteoclastogenesis. Findings in OVX rats support further evaluation of this formulation as a dietary intervention for estrogen deficiency-associated PMO; its efficacy in humans remains to be established.

doi.org/10.3390/foods15224094Open accessInterventions

AgingResearch.News